Mélanie Héroult
Bayer (Germany)(DE)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Proteoglycans and glycosaminoglycans research, Axon Guidance and Neuronal Signaling, Cell Adhesion Molecules Research, Fibroblast Growth Factor Research
Most-Cited Works
- → Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells(2017)559 cited
- → Collagen Triple Helix Repeat Containing 1, a Novel Secreted Protein in Injured and Diseased Arteries, Inhibits Collagen Expression and Promotes Cell Migration(2004)249 cited
- → Spheroid-based engineering of a human vasculature in mice(2008)214 cited
- → The Wnt signaling regulator R-spondin 3 promotes angioblast and vascular development(2008)168 cited
- → A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis(2009)163 cited
- → Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression(2005)160 cited
- → Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth(2015)158 cited
- → Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-binding Domain of Neuropilin-1(2008)128 cited
- → Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation(2016)100 cited
- → Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models(2019)98 cited